Categories: HealthcareNews

Streamline Health® Expands RevID™ Agreement with Large Provider Network, Achieves Booked SaaS ACV Goal

National Health System Expands Utilization of RevID’s Automated Charge Reconciliation for Improved Financial Performance; Company Exceeds $17M of Booked SaaS ACV 

Atlanta, GA, Jan. 19, 2023 (GLOBE NEWSWIRE) — Streamline Health Solutions, Inc. (NASDAQ: STRM), a leading provider of solutions that enable healthcare providers to improve financial performance, announced today an expansion of its existing relationship with a prominent healthcare system that manages 80+ facilities throughout the United States. The health system has further expanded its use of RevID. The Company also announced that it has now exceeded its previously stated goal of $17 million of booked SaaS ACV by the end of its fiscal 2022.

Streamline Health is leading an industry movement to improve hospital financial performance through pre-bill technology solutions. RevID’s automated charge reconciliation ensures that providers can accurately capture, bill and ultimately be paid for all the care they provide.

“We are pleased that this key healthcare provider continues to expand utilization of our novel RevID solution and thrilled that our sales team was able to execute on its SaaS bookings goals thus far in fiscal 2022” stated Ben Stilwill, President, Streamline Health. “We look forward to continued growth as a result of our mission to ensure that our nation’s healthcare providers are paid for the care they provide.”

About Streamline Health

Streamline Health Solutions, Inc. (Nasdaq: STRM) enables healthcare organizations to proactively address revenue leakage and improve financial performance. We deliver integrated solutions, technology-enabled services and analytics that drive compliant revenue leading to improved financial performance across the enterprise. For more information, visit www.streamlinehealth.net

To Learn More

Media
David Kosloski
Vice President, Marketing & Communications
651.308.1395
david.kosloski@streamlinehealth.net

Investors
Jacob Goldberger
Director, Investor Relations and FP&A
303.887.9625
jacob.goldberger@streamlinehealth.net

Staff

Recent Posts

Ad hoc: Novartis BidCo Germany AG Intends to Implement a Merger Squeeze-out of MorphoSys AG’s Minority Shareholders

PLANEGG and MUNICH, GERMANY / ACCESSWIRE / June 20, 2024 / MorphoSys AG (FSE:MOR)(NASDAQ:MOR) announces…

2 hours ago

Biophytis Extends Its Contract With Atlas to Secure Financing for Its Business Activities

Important note: Biophytis has set up financing in the form of Bonds redeemable in cash…

8 hours ago

Watertown Regional Medical Center Partners with HOPCo To Enhance Orthopedic and Spine Services

WATERTOWN, Wis. and PHOENIX, Ariz., June 19, 2024 /PRNewswire/ -- Watertown Regional Medical Center (WRMC)…

11 hours ago

Quest Diagnostics to Release Second Quarter 2024 Financial Results on July 23, 2024

SECAUCUS, N.J., June 19, 2024 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic…

11 hours ago

MULTI GRAMMY AWARD-WINNING ARTIST LIZZO KICKS OFF 5TH ANNUAL JUNETEENTH GIVEBACK FEATURING IMPACTFUL INITIATIVES AND INSPIRING CONVERSATIONS

LOS ANGELES, June 19, 2024 /PRNewswire/ -- For the fifth consecutive year, multi-Grammy Award and…

11 hours ago

MediOrbis(TM) Partners with Healthyr(TM) to Offer Proven Engagement, Longitudinal Care and Specialty

MediOrbis TM Partners with Healthyr to Offer Proven Engagement, Longitudinal Care and Specialty Telehealth Services…

14 hours ago